BLTE
Price
$59.22
Change
-$0.68 (-1.14%)
Updated
Jun 27, 04:54 PM (EDT)
Capitalization
1.95B
40 days until earnings call
CLDX
Price
$20.31
Change
-$0.86 (-4.06%)
Updated
Jun 27, 04:59 PM (EDT)
Capitalization
1.41B
41 days until earnings call
Interact to see
Advertisement

BLTE vs CLDX

Header iconBLTE vs CLDX Comparison
Open Charts BLTE vs CLDXBanner chart's image
Belite Bio
Price$59.22
Change-$0.68 (-1.14%)
Volume$200
Capitalization1.95B
Celldex Therapeutics
Price$20.31
Change-$0.86 (-4.06%)
Volume$17.49K
Capitalization1.41B
BLTE vs CLDX Comparison Chart in %
Loading...
BLTE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CLDX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BLTE vs. CLDX commentary
Jun 28, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BLTE is a Buy and CLDX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 28, 2025
Stock price -- (BLTE: $59.90 vs. CLDX: $21.17)
Brand notoriety: BLTE and CLDX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BLTE: 188% vs. CLDX: 79%
Market capitalization -- BLTE: $1.95B vs. CLDX: $1.41B
BLTE [@Biotechnology] is valued at $1.95B. CLDX’s [@Biotechnology] market capitalization is $1.41B. The market cap for tickers in the [@Biotechnology] industry ranges from $301.01B to $0. The average market capitalization across the [@Biotechnology] industry is $2.32B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BLTE’s FA Score shows that 0 FA rating(s) are green whileCLDX’s FA Score has 0 green FA rating(s).

  • BLTE’s FA Score: 0 green, 5 red.
  • CLDX’s FA Score: 0 green, 5 red.
According to our system of comparison, CLDX is a better buy in the long-term than BLTE.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BLTE’s TA Score shows that 3 TA indicator(s) are bullish while CLDX’s TA Score has 5 bullish TA indicator(s).

  • BLTE’s TA Score: 3 bullish, 6 bearish.
  • CLDX’s TA Score: 5 bullish, 2 bearish.
According to our system of comparison, CLDX is a better buy in the short-term than BLTE.

Price Growth

BLTE (@Biotechnology) experienced а -0.76% price change this week, while CLDX (@Biotechnology) price change was +1.68% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +8.46%. For the same industry, the average monthly price growth was +36.24%, and the average quarterly price growth was +15.15%.

Reported Earning Dates

BLTE is expected to report earnings on Aug 06, 2025.

CLDX is expected to report earnings on Aug 07, 2025.

Industries' Descriptions

@Biotechnology (+8.46% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BLTE($1.95B) has a higher market cap than CLDX($1.41B). BLTE YTD gains are higher at: -5.071 vs. CLDX (-16.225). BLTE has higher annual earnings (EBITDA): -43.31M vs. CLDX (-213.94M). CLDX has higher revenues than BLTE: CLDX (7.56M) vs BLTE (0).
BLTECLDXBLTE / CLDX
Capitalization1.95B1.41B139%
EBITDA-43.31M-213.94M20%
Gain YTD-5.071-16.22531%
P/E RatioN/AN/A-
Revenue07.56M-
Total CashN/A673M-
Total DebtN/A3.43M-
FUNDAMENTALS RATINGS
CLDX: Fundamental Ratings
CLDX
OUTLOOK RATING
1..100
54
VALUATION
overvalued / fair valued / undervalued
1..100
56
Fair valued
PROFIT vs RISK RATING
1..100
64
SMR RATING
1..100
94
PRICE GROWTH RATING
1..100
60
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
95

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BLTECLDX
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
74%
Bullish Trend 2 days ago
78%
Momentum
ODDS (%)
Bearish Trend 2 days ago
82%
Bullish Trend 2 days ago
86%
MACD
ODDS (%)
Bearish Trend 2 days ago
80%
Bullish Trend 2 days ago
75%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
79%
Bullish Trend 2 days ago
81%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
77%
Bullish Trend 2 days ago
79%
Advances
ODDS (%)
Bullish Trend 5 days ago
76%
N/A
Declines
ODDS (%)
Bearish Trend 17 days ago
82%
Bearish Trend 2 days ago
81%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
81%
Bearish Trend 2 days ago
84%
Aroon
ODDS (%)
Bearish Trend 2 days ago
74%
Bullish Trend 2 days ago
76%
View a ticker or compare two or three
Interact to see
Advertisement
BLTE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CLDX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
SMCWX71.910.91
+1.28%
American Funds SMALLCAP World A
IENRX9.650.11
+1.15%
Macquarie Climate Solutions R6
GCMAX36.00N/A
N/A
Goldman Sachs Mid Cap Value A
GSFPX17.36N/A
N/A
Goldman Sachs US Eq Div and Premium P
VGSAX35.80N/A
N/A
Virtus Duff & Phelps Glb Rl Estt Secs A

BLTE and

Correlation & Price change

A.I.dvisor indicates that over the last year, BLTE has been loosely correlated with RAIN. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if BLTE jumps, then RAIN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BLTE
1D Price
Change %
BLTE100%
-1.96%
RAIN - BLTE
48%
Loosely correlated
+7.43%
ACOG - BLTE
24%
Poorly correlated
-3.76%
CLDX - BLTE
22%
Poorly correlated
-1.35%
APLS - BLTE
22%
Poorly correlated
+0.05%
ALEC - BLTE
22%
Poorly correlated
+0.67%
More

CLDX and

Correlation & Price change

A.I.dvisor indicates that over the last year, CLDX has been loosely correlated with BEAM. These tickers have moved in lockstep 53% of the time. This A.I.-generated data suggests there is some statistical probability that if CLDX jumps, then BEAM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CLDX
1D Price
Change %
CLDX100%
-1.35%
BEAM - CLDX
53%
Loosely correlated
+2.27%
ATXS - CLDX
51%
Loosely correlated
-3.72%
CRNX - CLDX
50%
Loosely correlated
-1.38%
RVMD - CLDX
50%
Loosely correlated
-2.42%
DNLI - CLDX
49%
Loosely correlated
+0.28%
More